Regeneron Pharmaceuticals recalls
FDA enforcement reports naming Regeneron Pharmaceuticals Inc as the recalling firm.
- Recall reports
- 3
- Class I (serious)
- 0
- Most recent report
- Aug 26, 2026
- Aug 26, 2026Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous Infusion A…Drug · Regeneron Pharmaceuticals IncLack of Assurance of SterilityClass II
- Jun 5, 2024EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0Drug · Regeneron Pharmaceuticals IncLack of Assurance of Sterility: Complaints of syringe breakageClass II
- May 8, 2024EYLEA, (aflibercept) Injection, 2 mg (0Drug · Regeneron Pharmaceuticals IncLack of Assurance of Sterility: Complaints of syringe breakageClass II